entertainment -WSS

entertainment

author：hotspot 2025-09-07 13:59:13 - browse：9

FDA's Peter Marks talks with STAT's Adam Feuerstein — Peter Marks, the FDA's top regulator of gene therapies (right), speaks with STAT's Adam Feuerstein in San Francisco. Sarah Gonzalez/Peopletography for STAT

SAN FRANCISCO — Peter Marks, the Food and Drug Administration’s top regulator of gene therapies, seems very comfortable with granting some form of full approval to Elevidys, the Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy, based on his comments to me on Monday night during our “fireside chat” at a STAT event.

To be clear, Marks declined to comment specifically about the ongoing FDA review of Elevidys. I tried. However, Marks described a “hypothetical case” in the context of my Sarepta questions that clearly suggested the failure of an Elevidys confirmatory study in October didn’t bother him all that much.

“Hypothetically, if you had a product that used an aggregate scale and all of the components of that aggregate scale looked pretty good, or nearly all of them look pretty good, but the aggregate, for various reasons, didn’t come out perfectly. We approved products based on that,” Marks told me.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Eyeing GLP

explore

WSS

Bird flu surveillance in wastewater gets boost from consortium

H5N1 virus can be tracked in retail milk, scientists say

Citing H5N1 threat, CDC urges peak flu monitoring this summer

New definition of a human embryo proposed amid rapid advances

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Reports of telehealth's death have been greatly exaggerated

hotspot

entertainment

leisure time

Virginia high school admissions case could be legal follow

Majority of Americans think Trump's Ga. election interference case is serious: POLL

After affirmative action ruling, medical educators look to 'holistic review'

An interview with Robert F. Kennedy Jr. on vaccines

Duchenne breakthrough therapy leaves behind pioneering families

Bird flu surveillance in wastewater gets boost from consortium

Duchenne breakthrough therapy leaves behind pioneering families

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Trump demands the U.S. pay no more for drugs than other countries … again

As Maui death toll rises, number of missing remains unclear

Wikipedia

UnitedHealth argues against case alleging wrongful AI care denials

Scrutiny of post

Trump's false claims about Georgia's 2020 election long debunked

Bird flu surveillance in wastewater gets boost from consortium

Digital health: a case of mistaken identity

The pain doctors face in trying to build their families

explore

knowledge

explore

focus